| Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621) |
|---|
| 06/27/2007 | EP1272459B1 7- and 9-carbamate, urea, thiourea, thiocarbamate, and heteroaryl-amino substituted tetracycline compounds |
| 06/27/2007 | CN1989117A Substituted benzothiazoles |
| 06/27/2007 | CN1989116A Diphenylamine-substituted salicylthiazole derivatives and related compounds as phosphotyrosine phosphatase 1B (P T P 1 B) inhibitors for using as blood-sugar decreasing active ingredients for treating |
| 06/27/2007 | CN1989115A Oxazole derivatives as histamine h3 receptor agents, preparation and therapeutic uses |
| 06/27/2007 | CN1986533A Preparation and application of alkenyl amide cluster compound |
| 06/26/2007 | US7235690 Anthranilamides and methods of their use |
| 06/26/2007 | US7235669 Epothilone side components |
| 06/26/2007 | US7235668 Process for the preparation of thioalkylamine derivatives |
| 06/26/2007 | US7235667 N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation |
| 06/21/2007 | WO2007069773A1 A pharmaceutical composition comprising an amide derivative |
| 06/21/2007 | WO2007041365A3 3-cyclyl-2- (4-sulfamo yl-phenyl) -n-cyclyl-propionamide derivatives useful in the treatment of impaired glucose tolerance and diabetes |
| 06/21/2007 | WO2007030567A3 Pparactive compounds |
| 06/21/2007 | US20070142642 Method for the production of compounds with quaternary sp2-hybridised nitrogen atoms |
| 06/21/2007 | US20070142384 Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders |
| 06/21/2007 | US20070142381 Calcium receptor modulating agents |
| 06/21/2007 | US20070142375 Pyrrolidine derivatives as factor xa inhibitors |
| 06/21/2007 | US20070142374 e.g. 2-(4-Chlorophenyl)-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}ethenesulfonamide; blood coagulation factor and trypsin-like serine protease inhibitor; anticoagulant, antiinflammatory agent; atherosclerotic plaque, myocardial infarction and unstable angina |
| 06/21/2007 | US20070142353 such as 2-(3-(aminomethyl)pyrrolidin-1-yl)-4-(4-methoxybenzyl)-7-oxo-4,7-dihydro[1,3]thiazolo[4,5-b]pyridine-6-carboxylic acid, used for treating drug-resistant bacterial infections |
| 06/21/2007 | US20070142329 2-Chloro-N-[2-(2-chloro-phenyl)-ethyl]-5-(6-oxo-1,6-dihydro-pyrazin-3-yl)benzamide, for example; useful in the treatment of IL-1 mediated disorders, including inflammatory diseases such as osteoarthritis and rheumatoid arthritis, allergies, asthma, COPD, cancer |
| 06/21/2007 | US20070142246 Benzo[b]perhydroheterocyclic arylamines and lubricating oil compositions |
| 06/21/2007 | US20070141643 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 06/21/2007 | CA2631051A1 Organic compounds |
| 06/20/2007 | EP1798216A1 Intermediate of 6-substituted-1-methyl-1-h-benzimidazole derivative and method for producing same |
| 06/20/2007 | EP1797878A2 Benzothiazole derivatives |
| 06/20/2007 | EP1797094A2 1,3-disubstituted heteroaryl nmda/nr2b antagonists |
| 06/20/2007 | EP1797084A1 NOVEL HETEROCYCLIC NF-kB INHIBITORS |
| 06/20/2007 | EP1797065A2 Acyclic 1,3-diamines and uses therefor |
| 06/20/2007 | EP1797052A1 Bicyclic compounds which inhibit beta-secretase activity and methods of use thereof |
| 06/20/2007 | EP1797029A1 Method of deprotection |
| 06/20/2007 | EP1381590B1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 06/20/2007 | CN1984895A Synthesis and uses of synephrine derivatives |
| 06/20/2007 | CN1984889A Organometallic complex, luminous solid, organic EL element and organic EL display |
| 06/20/2007 | CN1984881A Method for producing enantiomeric form of 2, 3-diaminopropionic acid derivatives |
| 06/20/2007 | CN1982298A Hydro diamine compound, its production and use and composition containing it |
| 06/20/2007 | CN1321989C AE-active ester chemical synthesizing method |
| 06/20/2007 | CN1321964C Lightfast additive having uv-absorbing moiety and ink composition including the same |
| 06/20/2007 | CN1321682C New dipeptidyl peptidase iv inhibitors and their uses as anti-cancer agents |
| 06/19/2007 | US7232840 comprises a mixture with fungicidally active compounds, except for cyclopropylcarboxamide derivatives and azolylmethylcycloalkanes |
| 06/19/2007 | US7232838 2-amino-4,5-trisubstituted thiazolyl derivatives |
| 06/19/2007 | US7232792 3-heterocyclyl-substituted benzoyl derivatives |
| 06/19/2007 | US7232616 Complex |
| 06/14/2007 | WO2007067994A1 Inhibitors of histone deacetylase for the treatment of disease |
| 06/14/2007 | WO2007067993A1 Inhibitors of histone deacetylase for the treatment of disease |
| 06/14/2007 | WO2007067817A1 Abca1 elevating compounds |
| 06/14/2007 | US20070135630 Thiazolyl-substsituted carbocylic 1,3-diones as pesticidal agents |
| 06/14/2007 | US20070135523 Novel benzamidine derivatives having anti-inflammatory and immunosuppressive activity |
| 06/14/2007 | US20070135505 Aralkyl ester soft drugs |
| 06/14/2007 | US20070135497 Biphenyl derivative or its salt, and pesticide containing it as an active ingredient |
| 06/14/2007 | US20070135496 Substituted benzylaminoalkylene heterocycles |
| 06/14/2007 | US20070135440 Amide derivatives bearing a cyclopropylaminoacarbonyl substituent useful as cytokine inhibitors |
| 06/14/2007 | DE102005027589B3 Temperatur-/Bestrahlungs-/Polymerisationsindikatoren Temperature / radiation / Polymerisationsindikatoren |
| 06/14/2007 | CA2630666A1 Jasmonate derivatives, pharmaceutical compositions and methods of use thereof |
| 06/13/2007 | EP1794138A2 Thiazolo-naphthyl acids as inhibitors of plasminogen activator inhibitor-1 |
| 06/13/2007 | EP1794117A2 Mercaptoamides as histone deacetylase inhibitors |
| 06/13/2007 | EP1416931B1 Inhibitors of polyq-aggregation |
| 06/13/2007 | EP1299359B1 Chemical process for the extraction of 2-hydroxy pyridine derivatives, 2-hydroxyquinoline, and 2-hydroxybenzothiazole |
| 06/13/2007 | EP1214292B1 Tyrosine derivatives |
| 06/13/2007 | CN1980909A Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors |
| 06/13/2007 | CN1980908A Substituted thiazoleacetic as CRTH2 ligands |
| 06/13/2007 | CN1980907A Ritonavir analogous compound useful as retroviral protease inhibitor, preparation of the ritonavir analogous compound and pharmaceutical composition for the ritonavir analogous compound. |
| 06/13/2007 | CN1980906A Compounds and compositions as PPAR modulators |
| 06/13/2007 | CN1980905A An improved process for preparing n-hydroxy-4-{5- [4- (5-isopropyl-2-methyl-l, 3-thiazol-4-yl) -phenoxy] -pentoxy }-benzamidine |
| 06/13/2007 | CN1321101C New retinoids for the treatment of emphysema |
| 06/12/2007 | US7230111 Chlorinating an isothiocyanate; cyclization |
| 06/12/2007 | US7230088 Compounds for dual photodiagnosis and therapy |
| 06/12/2007 | US7230031 Thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof |
| 06/12/2007 | US7230021 Therapy for immunology sensitive disease; marine animal extract |
| 06/12/2007 | US7230020 For therapy of metabolic disorders, such as diabetes and obesity, cardiovascular disorders, such as hypertension, glaucoma, inflammatory disorders, such as arthritis or asthma, immune disorders, bone disorders, such as osteoporosis, cancer |
| 06/12/2007 | US7229998 Thiazole and oxazole derivatives as activators of human peroxisome proliferator activated receptors |
| 06/12/2007 | US7229988 for the treatment and/or prevention of medical dysfunctions and diseases such as stroke, Parkinson's disease, and Alzheimer's disease caused by reactive oxygen species and/or excess Zn ions; neuroprotectants |
| 06/12/2007 | US7229987 Oxazoles with one or more tertiary amine groups and phenyl groups, e.g., 1-{4-[2-(Benzofuran-2-ylmethoxymethyl)-oxazol-5-yl]-phenyl}-3-(2-dimethylamino-ethyl)-urea and -(3-{4-[2-(2-Phenoxy-ethylsulfanylmethyl)-oxazol-5-yl]-phenoxy}-propyl)-azepine; treating obesity and related diseases, e.g., diabetes |
| 06/12/2007 | CA2382581C Substituted benzylthiazolidine-2,4-dione derivatives |
| 06/12/2007 | CA2354023C Phenylglycine derivatives |
| 06/07/2007 | WO2007064891A1 Compositions and methods for inducing neuronal differentiation |
| 06/07/2007 | WO2007064773A2 Isotopically-labeled benzothiazole compounds as imaging agents for amyloidogenic proteins |
| 06/07/2007 | WO2007063928A1 Novel noncyclic amine carboxamide derivative and salt thereof |
| 06/07/2007 | WO2007063925A1 2-aminobenzamide derivative |
| 06/07/2007 | WO2007062797A1 Amino-substituted azo-heterocyclic compounds for treating inflammatory conditions |
| 06/07/2007 | WO2007045551A3 Renin inhibitors nitroderivatives |
| 06/07/2007 | WO2007038331A3 Novel chemical compounds |
| 06/07/2007 | WO2007014290A3 Fungicidal carboxamides |
| 06/07/2007 | WO2006097809B1 Novel tyrosine derivatives |
| 06/07/2007 | US20070129369 Heteroaryl substituted cyclohexyl-1,4-diamine compounds |
| 06/07/2007 | US20070129357 Novel crystals of fluorobenzamide derivative |
| 06/07/2007 | US20070129327 2-[(2-{(1R,2R)-2-[(1E)-4-hydroxy-4-methyl-1-nonenyl]-5-oxocyclopentyl}ethyl)sulfanyl]-1,3-thiazole-4-carboxylic acid; isomers; increase blood flow for improving symptoms such as lumbago, lower limb pain, lower limb numbness, intermittent claudication, bladder and rectal disorder or sexual dysfunction |
| 06/07/2007 | US20070124872 Method of coloring with capped diazotized compound and coupling component |
| 06/07/2007 | CA2631905A1 Isotopically-labeled benzothiazole compounds as imaging agents for amyloidogenic proteins |
| 06/07/2007 | CA2631750A1 Compositions and methods for inducing neuronal differentiation |
| 06/07/2007 | CA2629964A1 2-aminobenzamide derivative |
| 06/07/2007 | CA2628817A1 Iminopropene compound and use thereof |
| 06/06/2007 | EP1792905A1 Product containing at least one phosphatase CDC25 inhibitor combined with at least one other anticancer agent |
| 06/06/2007 | EP1792901A1 N-(1-alkyl-2-phenylethyl)-carboxamide derivatives and use thereof as fungicides |
| 06/06/2007 | EP1792888A1 Method for producing aminothiazole derivative and production intermediate |
| 06/06/2007 | EP1791835A2 Thiazole derivatives having vap-1 inhibitory activity |
| 06/06/2007 | EP1791822A1 Substituted n-acyl-2-aminothiazoles |
| 06/06/2007 | EP1791819A1 (hetero)cyclyl(thio) carboxylic acid anilides for controlling pathogenic fungi |
| 06/06/2007 | EP1791427A1 (hetero)cyclylcarboxamides for controlling pathogenic fungi |
| 06/06/2007 | EP1187833B1 Method of producing thiamethoxam |
| 06/06/2007 | CN1976910A Novel 2,4-diaminothiazol-5-one derivatives |
| 06/06/2007 | CN1976710A Compounds and compositions as cathepsin S inhibitors |